42313.1 IP-LS

Résumé

Selective Adsorption in Sepsis- towards clinical implementation

Textes supplémentaires

Abstract

Septic shock is a dysregulated immune response to infection that causes millions of deaths globally. Together with University of Bern, hemotunes advances its blood purification for specific and selective removal of multiple key drivers of sepsis to restore immune homeostasis and improve outcomes.

Participants

Lukas Langenegger

Wirtschaftspartner

lukas.langenegger@hemotune.ch

hemotune AG CHE-312.229.634 Lukas Langenegger Weinbergstrasse 35 8006 Zürich ZH CH

Joerg Schefold

Kontaktperson

joerg.schefold@insel.ch

Universität Bern Joerg Schefold Freiburgstrasse 18 3010 Bern BE CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2020-10-31
Date de fin: 2023-09-30
Coûts totaux approuvés: CHF 494477.01
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

B720 General practice, medical training 100.0%